In preparing and supporting your recommendation to either make the investment or not, include the following items as part of your analysis: Analysis of financial information. Identification of risks associated with the investment. Consider: How risky the project appears. How far off your estimates of revenues and expenses can be before your decision would change. The difference if the company were to use a straight line versus a MACRS depreciation. Recommendation for a course of action. Explanation of criteria supporting your recommendation. Financial Information As part of your analysis you might find that additional information from marketing, accounting, or finance would be useful in making an informed and well-supported recommendation. In a real workplace setting you would have the ability to ask for that information. However, for the purposes of this assessment, you can make assumptions about the values of that data or ratios in support of your recommendation. Accounting worked with the marketing group to create the ZXY Company Financial Statements spreadsheet (attached) for the new products business and the new facility. Notes about the financial information: The expense line labeled SQF FDA Mandates refers to the costs of complying with Food and Drug Administration requirements. Depreciation expense is calculated using 7-year life modified accelerated cost recovery system (MACR
Recent Comments
No comments to show.
Archives
- March 2026
- February 2026
- January 2026
- December 2025
- November 2025
- October 2025
- September 2025
- August 2025
- July 2025
- June 2025
- May 2025
- April 2025
- March 2025
- February 2025
- January 2025
- December 2024
- November 2024
- October 2024
- September 2024
- August 2024
- July 2024
- June 2024
- May 2024
- April 2024
- March 2024
- February 2024
- January 2024
